Sushil Patel

Sushil Patel

Chief Executive OfficeratReplimune Group· In proxies 2023–2025

Pay in FY2025+79% from the year before · Replimune Group stock +19.3% the same year

Sushil Patel was paid $3.7M in FY2025 (Mar), up 79%. Replimune Group stock rose 19.3% that year.

Pay$100 in the stock at the end of FY23 → $55
Pay is from the Summary Compensation Table of each Replimune Group proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Replimune GroupPublic company · 2 yr
    • Chief Executive Officer2024 – Present · 2 yrStock in role -19%
  2. Revolution MedicinesPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?